ENCORE SEOUL

  • Home
  • Contact us
회원로그인 ID PW Forgot ID/PW Register Automatically Log me on

Antiplatelet therapy beyond 2013 tailored medicine

▶ Predictions for Antiplatelet Therapy Beyond 2013
- Tailored therapy will be the norm.
- Better understanding the mechanism of treatment failure.
- In selected patients, thrombin pathway will be targeted.
- We will have the option of upstream vs. downstream parenteral platelet inhibition to achieve
maximal early PD effects.
- Platelet function testing will guide surgery timing in patients on antiplatelet therapy.
- Ethnicity will influence the dosing of antiplatelet therapy:
- a higher level of desirable on-treatment platelet reactivity in Asians vs. Caucasians

DETAIL VIEW
Best Focus

coronary

  • lecture
  • case
read more

vascular

  • lecture
  • case
read more

Family Site